OBLG Form 4: Director adds 10,000 shares, holds 61,351-share warrant

Rhea-AI Filing Summary

Oblong, Inc. director reports open-market share purchase and existing warrants. A company director bought 10,000 shares of Oblong common stock on 11/14/2025 at a price of $1.91 per share, bringing their directly held common stock position to 25,000 shares after the transaction. The filing also notes a previously issued Common Warrant with an exercise price of $3.4144, first exercisable on 10/01/2023 and expiring on 10/01/2028, covering 61,351 shares of common stock, all held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHECHTER JONATHAN

(Last) (First) (Middle)

110 16TH STREET

SUITE 1400 #1024

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oblong, Inc. [ OBLG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
COMMON STOCK	11/14/2025		P		10,000	A	$1.91	25,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Warrant(1)	$3.4144							10/01/2023	10/01/2028	Common Stock	61,351		61,351	D

Explanation of Responses:

1. Represents the issuance of warrants to purchase common stock of the issuer. The initial exercise date of the warrants was six months from the grant date, and the warrants expire on the fifth anniversary of the initial exercise date.

	/s/ Jonathan Schechter	11/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Oblong (OBLG) report in this Form 4?

A director of Oblong, Inc. reported buying 10,000 shares of common stock on 11/14/2025 at a price of $1.91 per share.

How many Oblong (OBLG) shares does the insider hold after the reported trade?

After the reported transaction, the director beneficially owns 25,000 shares of Oblong common stock in direct ownership.

What warrants related to Oblong (OBLG) are disclosed in this Form 4?

The filing discloses a Common Warrant with an exercise price of $3.4144, covering 61,351 shares of Oblong common stock.

When can the Oblong (OBLG) warrant be exercised and when does it expire?

The Common Warrant became exercisable on 10/01/2023 and expires on 10/01/2028, giving the holder a five-year exercise window from the initial exercise date.

What is the relationship of the reporting person to Oblong (OBLG)?

The reporting person is identified as a Director of Oblong, Inc. and filed the Form 4 as an individual reporting person.

Is the Oblong (OBLG) warrant held directly or indirectly by the insider?

The Form 4 shows the 61,351 Common Warrant-linked derivative securities as held in direct ownership by the reporting person.